Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Stage 3 Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT00602329
What this trial is testing

MRI in Predicting Response in Patients Receiving Combination Chemotherapy and Bevacizumab For Advanced or Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer
Abramson Cancer Center at Penn Medicine 5
Testing effectiveness (Phase 2)Study completedNCT00075881
What this trial is testing

Bortezomib in Treating Patients With Newly Diagnosed Multiple Myeloma

Who this might be right for
Stage I Multiple MyelomaStage II Multiple MyelomaStage III Multiple Myeloma
National Cancer Institute (NCI) 44
Large-scale testing (Phase 3)Active Not RecruitingNCT03937219
What this trial is testing

Study of Cabozantinib in Combination With Nivolumab and Ipilimumab in Patients With Previously Untreated Advanced or Metastatic Renal Cell Carcinoma

Who this might be right for
Renal Cell Carcinoma
Exelixis 855
Early research (Phase 1)Looking for participantsNCT06399419
What this trial is testing

CBM588 Capsules in Combination With Nivolumab and Ipilimumab for the Treatment of Advanced Stage Kidney Cancer

Who this might be right for
Advanced Clear Cell Renal Cell CarcinomaAdvanced Renal Cell CarcinomaAdvanced Sarcomatoid Renal Cell Carcinoma+5 more
Osel, Inc. 28
Not applicableNot Yet RecruitingNCT06726330
What this trial is testing

Risk-reducing Strategies, Including Fimbriectomy, in Women With a Germline Mutation Predisposing to Ovarian or Pelvic Cancer

Who this might be right for
Tubo-ovarian CarcinomaHigh-grade Serous CarcinomaPrimary Peritoneal Carcinoma Stage III+2 more
Centre Oscar Lambret 1,100
Not applicableUnknownNCT00445783
What this trial is testing

Study of Families With Melanoma

Who this might be right for
Melanoma (Skin)
Leeds Cancer Centre at St. James's University Hospital 3,700
Large-scale testing (Phase 3)Ended earlyNCT01875653
What this trial is testing

Autologous Dendritic Cell-Tumor Cell Immunotherapy for Metastatic Melanoma

Who this might be right for
Stage IV MelanomaStage III Melanoma
Lisata Therapeutics, Inc. 4
Large-scale testing (Phase 3)Ended earlyNCT04308395
What this trial is testing

Extension Study of Patidegib Topical Gel, 2% in Subjects With Gorlin Syndrome (Basal Cell Nevus Syndrome)

Who this might be right for
Basal Cell Nevus Syndrome
Sol-Gel Technologies, Ltd. 108
Early research (Phase 1)Study completedNCT03207529
What this trial is testing

Alpelisib and Enzalutamide in Treating Patients With Androgen Receptor and PTEN Positive Metastatic Breast Cancer

Who this might be right for
Advanced Breast CarcinomaAnatomic Stage III Breast Cancer AJCC v8Anatomic Stage IIIA Breast Cancer AJCC v8+15 more
M.D. Anderson Cancer Center 18
Testing effectiveness (Phase 2)Study completedNCT00017212
What this trial is testing

DX-8951f in Treating Patients With Metastatic Stomach Cancer

Who this might be right for
Esophageal CancerGastric Cancer
Daiichi Sankyo
Early research (Phase 1)Study completedNCT01293630
What this trial is testing

A Dose-escalation Study of Ombrabulin in Combination With Paclitaxel and Carboplatin in Patients With Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumors
Sanofi 18
Large-scale testing (Phase 3)Looking for participantsNCT05582265
What this trial is testing

Tislelizumab Combined With Chemotherapy Followed by Surgery Versus Up-front Surgery in Resectable Head and Neck Squamous Cell Carcinoma (REDUCTION-I)

Who this might be right for
Head and Neck Squamous Cell Carcinomas
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 537
Large-scale testing (Phase 3)UnknownNCT03428373
What this trial is testing

Rivaroxaban or Aspirin As Thromboprophylaxis in Multiple Myeloma

Who this might be right for
Multiple Myeloma in RelapseMultiple Myeloma ProgressionMultiple Myeloma Stage II+3 more
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's 57
Large-scale testing (Phase 3)Study completedNCT00030654
What this trial is testing

Hormone Therapy Plus Chemotherapy in Treating Patients With Prostate Cancer

Who this might be right for
Prostate Cancer
Radiation Therapy Oncology Group 21
Testing effectiveness (Phase 2)WithdrawnNCT04995094
What this trial is testing

Study of Neoadjuvant Imprime PGG and Pembrolizumab for Stage III, Resectable Melanoma

Who this might be right for
Pathologic Stage III Cutaneous Melanoma AJCC v8
HiberCell, Inc.
Not applicableStudy completedNCT02235051
What this trial is testing

Exercise Intervention in Preventing Breast Cancer Recurrence in Postmenopausal Breast Cancer Survivors

Who this might be right for
Cancer SurvivorEstrogen Receptor-positive Breast CancerStage IA Breast Cancer+5 more
City of Hope Medical Center 50
Not applicableEnrolling By InvitationNCT07030231
What this trial is testing

Use of Intraoperative Radiotherapy in Breast Cancer

Who this might be right for
Breast Cancer Early Stage Breast Cancer (Stage 1-3)
Parc de Salut Mar 3,000
Not applicableLooking for participantsNCT06508775
What this trial is testing

Long-Term Follow-up of Patients Treated With Miltenyi Cell and Gene Therapies

Who this might be right for
Melanoma Stage IIIB-cell Non Hodgkin LymphomaPediatric ALL+4 more
Miltenyi Biomedicine GmbH 40
Large-scale testing (Phase 3)Study completedNCT03009981
What this trial is testing

Androgen Annihilation in High-Risk Biochemically Relapsed Prostate Cancer

Who this might be right for
Prostate Cancer
Alliance Foundation Trials, LLC. 504
Early research (Phase 1)Study completedNCT04601766
What this trial is testing

A Phase I, Two-phase, Crossover Study to Evaluate the Safety, Tolerability and Pharmacokinetics of APL-1501 ER Tablets

Who this might be right for
Bladder Cancer
Asieris Pharmaceuticals (AUS) Pty Ltd. 12
Next Page